AMBB.Y Stock Overview
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Ambu A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr.15.85 |
| 52 Week High | kr.17.48 |
| 52 Week Low | kr.9.45 |
| Beta | 0.87 |
| 1 Month Change | -4.95% |
| 3 Month Change | -3.19% |
| 1 Year Change | 3.71% |
| 3 Year Change | -72.84% |
| 5 Year Change | -45.89% |
| Change since IPO | 20.06% |
Recent News & Updates
Recent updates
Shareholder Returns
| AMBB.Y | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -0.4% | -2.9% | -3.2% |
| 1Y | 3.7% | -3.7% | 19.3% |
Return vs Industry: AMBB.Y exceeded the US Medical Equipment industry which returned -3.7% over the past year.
Return vs Market: AMBB.Y underperformed the US Market which returned 19.3% over the past year.
Price Volatility
| AMBB.Y volatility | |
|---|---|
| AMBB.Y Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: AMBB.Y has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine AMBB.Y's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1937 | 4,600 | Britt Jensen | www.ambu.com |
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.
Ambu A/S Fundamentals Summary
| AMBB.Y fundamental statistics | |
|---|---|
| Market cap | US$4.18b |
| Earnings (TTM) | US$33.98m |
| Revenue (TTM) | US$699.12m |
123.1x
P/E Ratio6.0x
P/S RatioIs AMBB.Y overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AMBB.Y income statement (TTM) | |
|---|---|
| Revenue | kr.4.90b |
| Cost of Revenue | kr.2.11b |
| Gross Profit | kr.2.79b |
| Other Expenses | kr.2.55b |
| Earnings | kr.238.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 14, 2024
| Earnings per share (EPS) | 0.89 |
| Gross Margin | 56.97% |
| Net Profit Margin | 4.86% |
| Debt/Equity Ratio | 0% |
How did AMBB.Y perform over the long term?
See historical performance and comparison